A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: Strengths and weaknesses

Experimental Lung Research

Volumn 31, Issue 1, 2005, Pages 3-18

  Witschi, Hanspeter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A J mouse; Chemoprevention; Lung tumors; Mice; Tobacco smoke

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOISOCYANATE; ACETYLSALICYLIC ACID; BENZENE DERIVATIVE; BENZYL ISOTHIOCYANATE; BETA CAROTENE; BOWMAN BIRK INHIBITOR; CARCINOGEN; DEXAMETHASONE; INOSITOL; ISOCYANIC ACID DERIVATIVE; LIMONENE; PHENYL ISOTHIOCYANATE; SELENIUM DERIVATIVE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASSAY; CANCER INCIDENCE; CANCER MODEL; CONFERENCE PAPER; DRUG EFFICACY; EXPOSURE; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUSPENDED PARTICULATE MATTER;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INHALATION EXPOSURE; LUNG NEOPLASMS; MICE; MICE, INBRED A; TOBACCO SMOKE POLLUTION;

EID: 11144248346     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490494959     Document Type: Conference Paper

References (65)

1. Lorenz E, Stewart HL, Daniel JH, Warren S: The effects of breathing tobacco smoke on strain A mice. Cancer Res. 1943;3:123.
2. Essenberg JM: Cigarette smoke and the incidence of primary neoplasm of the lung in the albino mouse. Science. 1952;116:561-562.
3. Essenberg JM, Horowitz M, Gaffney E: The incidence of lung tumors in albino mice exposed to the smoke from cigarettes low in nicotine content. West J Surg Obstet Gynecol. 1955;63:265-267.
4. Essenberg JM: The effects of arsenic in tobacco on primary neoplasms of the lungs of albino mice. West J Surg Obstet Gynecol. 1956;64:35-36.
5. National Cancer Institute: Health Effects of Exposure to Environmental Tobacco Smoke: The Report of the California Environmental Protection Agency. Smoking and Tobacco Control Monograph No. 10. Bethesda MD: U.S. Department of Health and Human Services. NIH Pub. No. 99-4645, 1999.
6. Witschi HP, Oreffo VIC, Pinkerton KE: Six month exposure of strain A/J mice to cigarette sidestream smoke: cell kinetics and lung tumor data. Fundam Appl Toxicol. 1995;26:32-40.
7. Finch GL, Nikula KJ, Belinsky SA, Barr EB, Stoner GD, Lechner JF: Failure of cigarette smoke to induce or promote lung cancer in the A/J mouse. Cancer Lett. 1996;99:161-167.
8. Witschi HP, Espiritu I, Peake JL, Wu K, Maronpot RR, Pinkerton KE: The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997;18:575-586.
9. Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, Jenkins RA, et al: Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol. 1994;6:79-93.
10. D'Agostini F, Balansky RM, Bennicelli C, Lubet RA, Kelloff GJ, De Flora S: Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int J Oncol. 2001;18:607-615.
11. Stinn W, Kuhl H, Haussmann HJ: The role of cigarette smoke exposure-related stress in the A/J mouse lung tumorigenesis model. Toxicol Lett. 2002;135:S70.
12. Curtin GM, Higuchi MA, Ayres PH, Swauger JE, Mosberg AT: Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation. Toxicol Sci. 2004;81:26-34.
13. Witschi HP, Espiritu , Uyeminami D, Suffia M, Pinkerton KB: Lung tumor response in strain A mice exposed to tobacco smoke: some dose-effect relationships. Inhal Toxicol. 2004;16:27-32.
14. IARC (International Agency for Research on Cancer). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Tobacco Smoking and Involuntary Smoking. Volume 83. Lyon: IARC;2004.
15. Henry CJ, Kouri RE: Chronic inhalation studies in mice. II. Effects of long-term exposure to 2R1 cigarette smoke on (C57BL/Cum × C3H/AnfCum)F1 mice. J Natl Cancer Inst. 1986;77:203-212.
16. Thun MJ, Henley SJ, Calle EE: Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene. 2002;21:7307-7325.
17. Pisani P, Parkin DM, Bray F, Ferlay J: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
18. Lam TH, Ho SY, Hedley AJ, Mak KH, Peto R: Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ 2001;323:361.
19. Bogen KT, Witschi H: Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk. Carcinogenesis 2002;23:511-519.
20. Shimkin MB, Stoner GD: Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res. 1975;21:1-58.
21. Stoner GD, Shimkin MB: Lung tumors in strain A mice as a bioassay for carcinogenicity. In: Milman H, Weisburger EK, eds. Handbook of Carcinogen Testing. Park Ridge NJ: Noyes Publications; 1985:179-214.
22. Witschi H, Espiritu I, Pinkerton KE, Murphy K, Maronpot R: Ozone Carcinogenesis revisited. Toxicol Sci. 1999;52:162-167.
23. Maronpot RR, Shimkin MB, Witschi HP, Smith LH, Cline JM: Strain A mouse pulmonary tumor test results for chemicals previously tested in the National Cancer Institute carcinogenicity tests. J Natl Cancer Inst. 1986;76:1101-1112.
24. Cohen SM, Robinson D, MacDonald J: Alternative models for carcinogenicity testing. Toxicol Sci. 2001;64:14-19.
25. Hoffmann D, Hoffmann I, Wynder EL: Lung cancer and the changing cigarette. IARC Sci Publ. 1991;105:449-459.
26. Dixon D, Horton J, Haseman JK, Talley F, Greenwell A, Nettesheim P, et al: Histomorphology and ultrastructure of spontaneous pulmonary neoplasms in strain A mice. Exp Lung Res. 1991;17: 131-155.
27. Witschi H, Espiritu I, Dance ST, Miller MS: A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol Sci. 2002;68:322-330.
28. Foley JF, Anderson MW, Stoner GD, Gaul BW, Hardisty JF, Maronpot RR: Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp Lung Res. 1991;17:157-168.
29. Lantry LE, Zhang Z, Gao F, Crist KA, Wang Y, Kelloff GJ, et al: Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem Suppl. 1997;27:20-25.
30. You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW: Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc Natl Acad Sci USA. 1989;86:3070-3074.
31. Ahrendt SA, Decker PA, Alawi EA, Zhu YR, Sanchez-Cespedes M, Yang SC, et al: Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. 2001;92:1525-1530.
32. Knoerr C, Stinn W, Vanscheeuwick P, Kindt HR, Haussmann HJ: Evaluation of evidence to explain the lung tumorigenesis in A/J mice induced by exposure to an environmental tobacco smoke surrogate. Toxicol Sci. 2003;72(S1):237.
33. Stoner GD, Adam-Rodwell G, Morse MA: Lung tumors in strain A mice: application for studies in cancer chemoprevention. J Cell Biochem Suppl. 1993;17F:95-103.
34. Hecht SS: Chemoprevention by isothiocyanates. J Cell Biochem Suppl. 1995;22:195-209.
35. Herzog CR, Lubet RA, You M: Genetic alterations in mouse lung tumors: implications for cancer chemoprevention. J Cell Biochem Suppl. 1997;28-29:49-63.
36. You M, Bergman G: Preclinical and clinical models of lung cancer chemoprevention. Hematol Oncol Clin North Am. 1998;12:1037-1053.
37. Malkinson AM: Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer. 2001;32:265-279.
38. Wattenberg LW, Estensen RD: Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1- butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 1996;56:5132-5135.
39. Gunning WT, Kramer PM, Lubet RA, Steele VE, Pereira MA: Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res. 2000;26:757-772.
40. Hecht SS, Kenney PM, Wang M, Upadhyaya P: Dose-response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo(a)pyrene and 4-(methylnitrosamino)-1-(S-pyridyl)-1-butanone. Cancer Lett. 2001;167:1-6.
41. Witschi H, Espiritu I, Uyeminami D: Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone. Carcinogenesis. 1999;20:1375-1378.
42. Witschi H, Uyeminami D, Moran D, Espiritu I: Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure. Carcinogenesis. 2000;21:977-982.
43. Witschi H. Tobacco Toxicology Revisited. In: Dansette PM, Snyder R, Dealforge M, Gibson GG, Greim H, Jollow DJ, et al, eds. Biological Reactive Intermediates VI. New York: Kluwer Academic/ Plenum Publishers; 2001:471-478.
44. Witschi H, Espiritu I, Ly M, Uyeminami D: The effects of dietary myoinositol on lung tumor development in tobacco smoke-exposed mice. Inhal Toxicol. 2004;16:195-201.
45. Mann MD, Grouse DA, Prentice ED: Appropriate animal numbers in biomedical research in light of animal welfare considerations. Lab Anim Sci 1991;41:6-14.
46. Witschi H, Espiritu I, Yu M, Willits NH: The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice. Carcinogenesis. 1998;19: 1789-1794.
47. De Flora S, Izzotti A, D' Agostini F, Balansky R: Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking- and oxidative stress-related end-points. Carcinogenesis. 2001;22:999-1013.
48. De Flora S, D'Agostini F, Balansky R, Camoirano A, Bennicelli C, Bagnasco M, et al: Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutat Res. 2003;523/524: 237-252.
49. van Zandwijk N, Dalesio O, Pastorino U, De Vries N, van Tinteren H: EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst. 2000;92:977-986.
50. Obermueller-Jevic UC, Espiritu I, Corbacho AM, Cross CE, Witschi H: Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol Sci. 2002;69:23-29.
51. Omenn GS: Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health. 1998;19:73-99.
52. Coggins CRE: A minireview of chronic animal inhalation studies with mainstream cigarette smoke. Inhal Toxicol. 2002;14:991-1002.
53. Mertens VE: Zigarettenrauch eine Ursache des Lungenkrebses? (Eine Anregung). Zeitschrift fuer Krebsforschung. 1930;32:82-91.
54. Mohr U, Reznik G: Tobacco carcinogenesis. In: Harris CC, ed. Pathogenesis and Therapy of Lung Cancer. New York: Marcel Dekker; 1978:263-368.
55. Coggins CRE: A review of the chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol. Pathol. 1998;26:307-314.
56. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91:1194-1210.
57. De Flora S, Balansky RM, D'Agostini F, Izzotti A, Camoirano A, Bennicelli C, et al: Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke. Cancer Res. 2003;63:793-800.
58. Witschi H, Espiritu I: Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC). Cancer Lett. 2002;183:141-146.
59. Witschi HP, Espiritu I, Maronpot RR, Pinkerton KE, Jones AD: The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis. 1997;18:2035-2042.
60. Wagner BM, Cline MJ, Dungworth DL, Fischer TH, Gardner DE, Pryor WA, et al: A safer cigarette? A comparative study. A consensus report. Inhal Toxicol. 2000;12(Suppl 5):1-48.
61. Stratton K, Shetty P, Wallace R, Bondurant S: Clearing the Smoke. Assessing the Science Base for Tobacco Harm Reduction. Washington DC: National Academy Press; 2001.
62. Izzotti A, Balansky RM, Dagostini F, Bennicelli C, Myers SR, Grubbs CJ, et al: Modulation of biomarkers by chemopreventive agents in smoke-exposed rats. Cancer Res. 2001;61:2472-2479.
63. Omenn GS: Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches. J Natl Cancer Inst. 2000;92:959-960.
64. Witschi HP: Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology. 1981;21:95-104.
65. John LC: Assessment of murine lung tumour development: a comparison of two techniques. Br J Biomed Sci. 2001;58:159-163.